Percutaneous tumor ablation for hepatocellular carcinoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21940565.
- Also identified by DOI 10.2214/AJR.11.7656.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This report reviews the current clinical status of percutaneous ablation of hepatocellular carcinoma (HCC). HCC is increasing in incidence. Multiple percutaneous ablation methods are now available for primary treatment or for bridging to transplantation. Percutaneous ethanol instillation and radiofrequency ablation are the most extensively evaluated percutaneous treatments for HCC. Newer technologies are being evaluated and may change future practice patterns.
Medical subject headings
- Carcinoma, Hepatocellular
- Catheter Ablation
- Liver Neoplasms